chemotherapy regimens typical in neoadjuvant settings
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for chemotherapy regimens typical in neoadjuvant settings, covering 2023-03-06 to 2023-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling [Phase 2]